Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Biogen (BIIB)

Biogen says Chief Legal Officer Susan Alexander will depart at end of May 2026

Neutral Impact 3 of 5 leadership Written later

Biogen announced that Chief Legal Officer Susan H. Alexander will leave the company effective at the end of May 2026. The company has started a search for her successor, so shareholders will not yet know who will lead its legal function.

Key points

  • Susan H. Alexander, Chief Legal Officer, will depart effective at the end of May 2026.
  • Biogen has initiated a search to identify its next Chief Legal Officer.
  • The announcement was made March 11, 2026, in an SEC Form 8-K filing.

The filing

CompanyBiogen (BIIB)
Form8-K, current report
Filed with the SECMar 11, 2026, 5:28 PM ET
Accession number0000950157-26-000280

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:30 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on March 11, 2026.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.